High resolution electron energy loss spectroscopy of MnO(100) and oxidized MnO(100)

Single crystal MnO(100) substrates can be selectively oxidized to produce Mn2O3- and Mn3O4-like surfaces under mild oxidation/reduction conditions readily accessed under ultrahigh vacuum (UHV). MnO(100) yields a characteristic Mn 2p x-ray photoelectron spectroscopy (XPS) satellite structure and appropriate O/Mn concentrations from O 1s/Mn 2p XPS intensity ratios. Its high resolution electron energy loss (HREEL) spectrum shows a series of Fuchs–Kliewer multiple phonon excitations with a single loss energy of 70.9 meV, characteristic of the cubic manganese monoxide structure. However, the HREEL spectral (HREELS) background is high and the phonons are not as well resolved as those typically observed on comparable metal monoxides. Annealing the MnO(100) substrate at 625 K and 5×10-7 Torr O2 slowly forms Mn2O3, as indicated by O 1s and Mn 2p XPS, and does so without significantly altering the symmetry of the MnO(100) low energy electron diffraction pattern. The MnO(100)-Mn2O3 surface can be selectively reduced to Mn3O4-like composition by heating under UHV to 775 K and to MnO(100) at 1000 K. HREEL spectra for the UHV annealed surfaces are well-resolved, and for the MnO(100)-Mn3O4 substrate a second fundamental phonon loss is observed at 55.6 meV as a result of the lower symmetry of the Mn3O4 spinel structure. The UHV-annealed MnO(100) surface appears to be more highly ordered since its HREELS phonon loss peaks are better resolved. It is also somewhat reduced, however, resulting in a less intense phonon spectrum with a fundamental loss energy of only 65.1 meV

High resolution electron energy loss spectroscopy of MnO(100) and oxidized MnO(100)

Single crystal MnO(100) substrates can be selectively oxidized to produce Mn2O3- and Mn3O4-like surfaces under mild oxidation/reduction conditions readily accessed under ultrahigh vacuum (UHV). MnO(100) yields a characteristic Mn 2p x-ray photoelectron spectroscopy (XPS) satellite structure and appropriate O/Mn concentrations from O 1s/Mn 2p XPS intensity ratios. Its high resolution electron energy loss (HREEL) spectrum shows a series of Fuchs–Kliewer multiple phonon excitations with a single loss energy of 70.9 meV, characteristic of the cubic manganese monoxide structure. However, the HREEL spectral (HREELS) background is high and the phonons are not as well resolved as those typically observed on comparable metal monoxides. Annealing the MnO(100) substrate at 625 K and 5×10-7 Torr O2 slowly forms Mn2O3, as indicated by O 1s and Mn 2p XPS, and does so without significantly altering the symmetry of the MnO(100) low energy electron diffraction pattern. The MnO(100)-Mn2O3 surface can be selectively reduced to Mn3O4-like composition by heating under UHV to 775 K and to MnO(100) at 1000 K. HREEL spectra for the UHV annealed surfaces are well-resolved, and for the MnO(100)-Mn3O4 substrate a second fundamental phonon loss is observed at 55.6 meV as a result of the lower symmetry of the Mn3O4 spinel structure. The UHV-annealed MnO(100) surface appears to be more highly ordered since its HREELS phonon loss peaks are better resolved. It is also somewhat reduced, however, resulting in a less intense phonon spectrum with a fundamental loss energy of only 65.1 meV

A Seat at the Table: Strategic Engagement in Service Activities for Early-Career Faculty From Underrepresented Groups in the Academy

Many academic institutions strive to promote more diverse and inclusive campuses for faculty, staff, and students. As part of this effort, these institutions seek to include individuals from historically underrepresented groups (URGs)-such as women, people from racial/ethnic minority populations, persons with disabilities-on committees and in other service activities. However, given the low number of faculty members from URGs at many institutions, these faculty members tend to receive more requests to provide service to the institution or department (e.g., serving on committees, mentoring) than their counterparts from majority groups. Faculty members from URGs, especially early-career faculty, thus risk becoming overburdened with providing service at the expense of working on other scholarly activities required for promotion and tenure (i.e., conducting research, publishing). Although many scholars and others have written about this "minority tax" and its implications for early-career faculty from underrepresented racial/ethnic minority groups, fewer have published about how this tax extends beyond racial/ethnic minorities to women and persons with disabilities. Further, the literature provides scant practical advice on how to avoid overburdening early-career faculty from URGs. Here, a group of multidisciplinary early- and mid-career faculty members from URGs seek to provide their peers from URGs with practical strategies for both evaluating the appropriateness of service requests and declining those that are not a good fit. The authors also provide institutional leaders with actionable recommendations to prevent early-career faculty from URGs from becoming overburdened with service

Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score.

OBJECTIVE: To develop and validate a pragmatic risk score to predict mortality in patients admitted to hospital with coronavirus disease 2019 (covid-19). DESIGN: Prospective observational cohort study. SETTING: International Severe Acute Respiratory and emerging Infections Consortium (ISARIC) World Health Organization (WHO) Clinical Characterisation Protocol UK (CCP-UK) study (performed by the ISARIC Coronavirus Clinical Characterisation Consortium-ISARIC-4C) in 260 hospitals across England, Scotland, and Wales. Model training was performed on a cohort of patients recruited between 6 February and 20 May 2020, with validation conducted on a second cohort of patients recruited after model development between 21 May and 29 June 2020. PARTICIPANTS: Adults (age ≥18 years) admitted to hospital with covid-19 at least four weeks before final data extraction. MAIN OUTCOME MEASURE: In-hospital mortality. RESULTS: 35 463 patients were included in the derivation dataset (mortality rate 32.2%) and 22 361 in the validation dataset (mortality rate 30.1%). The final 4C Mortality Score included eight variables readily available at initial hospital assessment: age, sex, number of comorbidities, respiratory rate, peripheral oxygen saturation, level of consciousness, urea level, and C reactive protein (score range 0-21 points). The 4C Score showed high discrimination for mortality (derivation cohort: area under the receiver operating characteristic curve 0.79, 95% confidence interval 0.78 to 0.79; validation cohort: 0.77, 0.76 to 0.77) with excellent calibration (validation: calibration-in-the-large=0, slope=1.0). Patients with a score of at least 15 (n=4158, 19%) had a 62% mortality (positive predictive value 62%) compared with 1% mortality for those with a score of 3 or less (n=1650, 7%; negative predictive value 99%). Discriminatory performance was higher than 15 pre-existing risk stratification scores (area under the receiver operating characteristic curve range 0.61-0.76), with scores developed in other covid-19 cohorts often performing poorly (range 0.63-0.73). CONCLUSIONS: An easy-to-use risk stratification score has been developed and validated based on commonly available parameters at hospital presentation. The 4C Mortality Score outperformed existing scores, showed utility to directly inform clinical decision making, and can be used to stratify patients admitted to hospital with covid-19 into different management groups. The score should be further validated to determine its applicability in other populations. STUDY REGISTRATION: ISRCTN66726260

Delayed mucosal anti-viral responses despite robust peripheral inflammation in fatal COVID-19

Background While inflammatory and immune responses to SARS-CoV-2 infection in peripheral blood are extensively described, responses at the upper respiratory mucosal site of initial infection are relatively poorly defined. We sought to identify mucosal cytokine/chemokine signatures that distinguished COVID-19 severity categories, and relate these to disease progression and peripheral inflammation. Methods We measured 35 cytokines and chemokines in nasal samples from 274 patients hospitalised with COVID-19. Analysis considered the timing of sampling during disease, as either the early (0-5 days post-symptom onset) or late (6-20 days post-symptom onset). Results Patients that survived severe COVID-19 showed IFN-dominated mucosal immune responses (IFN-γ, CXCL10 and CXCL13) early in infection. These early mucosal responses were absent in patients that would progress to fatal disease despite equivalent SARS-CoV-2 viral load. Mucosal inflammation in later disease was dominated by IL-2, IL-10, IFN-γ, and IL-12p70, which scaled with severity but did not differentiate patients who would survive or succumb to disease. Cytokines and chemokines in the mucosa showed distinctions from responses evident in the peripheral blood, particularly during fatal disease. Conclusions Defective early mucosal anti-viral responses anticipate fatal COVID-19 but are not associated with viral load. Early mucosal immune responses may define the trajectory of severe COVID-19

Large-scale phenotyping of patients with long COVID post-hospitalization reveals mechanistic subtypes of disease

One in ten severe acute respiratory syndrome coronavirus 2 infections result in prolonged symptoms termed long coronavirus disease (COVID), yet disease phenotypes and mechanisms are poorly understood1. Here we profiled 368 plasma proteins in 657 participants ≥3 months following hospitalization. Of these, 426 had at least one long COVID symptom and 233 had fully recovered. Elevated markers of myeloid inflammation and complement activation were associated with long COVID. IL-1R2, MATN2 and COLEC12 were associated with cardiorespiratory symptoms, fatigue and anxiety/depression; MATN2, CSF3 and C1QA were elevated in gastrointestinal symptoms and C1QA was elevated in cognitive impairment. Additional markers of alterations in nerve tissue repair (SPON-1 and NFASC) were elevated in those with cognitive impairment and SCG3, suggestive of brain–gut axis disturbance, was elevated in gastrointestinal symptoms. Severe acute respiratory syndrome coronavirus 2-specific immunoglobulin G (IgG) was persistently elevated in some individuals with long COVID, but virus was not detected in sputum. Analysis of inflammatory markers in nasal fluids showed no association with symptoms. Our study aimed to understand inflammatory processes that underlie long COVID and was not designed for biomarker discovery. Our findings suggest that specific inflammatory pathways related to tissue damage are implicated in subtypes of long COVID, which might be targeted in future therapeutic trials

Post-acute COVID-19 neuropsychiatric symptoms are not associated with ongoing nervous system injury

A proportion of patients infected with severe acute respiratory syndrome coronavirus 2 experience a range of neuropsychiatric symptoms months after infection, including cognitive deficits, depression and anxiety. The mechanisms underpinning such symptoms remain elusive. Recent research has demonstrated that nervous system injury can occur during COVID-19. Whether ongoing neural injury in the months after COVID-19 accounts for the ongoing or emergent neuropsychiatric symptoms is unclear. Within a large prospective cohort study of adult survivors who were hospitalized for severe acute respiratory syndrome coronavirus 2 infection, we analysed plasma markers of nervous system injury and astrocytic activation, measured 6 months post-infection: neurofilament light, glial fibrillary acidic protein and total tau protein. We assessed whether these markers were associated with the severity of the acute COVID-19 illness and with post-acute neuropsychiatric symptoms (as measured by the Patient Health Questionnaire for depression, the General Anxiety Disorder assessment for anxiety, the Montreal Cognitive Assessment for objective cognitive deficit and the cognitive items of the Patient Symptom Questionnaire for subjective cognitive deficit) at 6 months and 1 year post-hospital discharge from COVID-19. No robust associations were found between markers of nervous system injury and severity of acute COVID-19 (except for an association of small effect size between duration of admission and neurofilament light) nor with post-acute neuropsychiatric symptoms. These results suggest that ongoing neuropsychiatric symptoms are not due to ongoing neural injury

The Arequipa Massif of Peru : new SHRIMP and isotope constraints on a Paleoproterozoic inlier in the Grenvillian orogen

The enigmatic Arequipa Massif of southwestern Peru is an outcrop of Andean basement that underwent Grenville-age metamorphism, and as such it is important for the better constraint of Laurentia–Amazonia ties in Rodinia reconstruction models. U–Pb SHRIMP zircon dating has yielded new evidence on the evolution of the Massif between Middle Paleoproterozoic and Early Paleozoic. The oldest rock-forming events occurred in major orogenic events between ca. 1.79 and 2.1 Ga (Orosirian to Rhyacian), involving early magmatism (1.89–2.1 Ga, presumably emplaced through partly Archaean continental crust), sedimentation of a thick sequence of terrigenous sediments, UHT metamorphism at ca. 1.87 Ga, and late felsic magmatism at ca. 1.79 Ga. The Atico sedimentary basin developed in the Late-Mesoproterozoic and detrital zircons were fed from a source area similar to the high-grade Paleoproterozoic basement, but also from an unknown source that provided Mesoproterozoic zircons of 1200–1600 Ma. The Grenville-age metamorphism was of low-P type; it both reworked the Paleoproterozoic rocks and also affected the Atico sedimentary rocks. Metamorphism was diachronous: ca. 1040 Ma in the Quilca and Camaná areas and in the San Juán Marcona domain, 940 ± 6 Ma in the Mollendo area, and between 1000 and 850 Ma in the Atico domain. These metamorphic domains are probably tectonically juxtaposed. Comparison with coeval Grenvillian processes in Laurentia and in southern Amazonia raises the possibility that Grenvillian metamorphism in the Arequipa Massif resulted from extension and not from collision. The Arequipa Massif experienced Ordovician–Silurian magmatism at ca. 465 Ma, including anorthosites formerly considered to be Grenvillian, and high-T metamorphism deep within the magmatic arc. Focused retrogression along shear zones or unconformities took place between 430 and 440 Ma